Epocrates, Inc. is transforming the practice of medicine by developing innovative solutions that support clinical decisions at the point of care. More than 500,000 healthcare professionals, including more than one in four U.S. physicians, actively use Epocrates’ mobile and web-based products to improve patient safety and save time. The Epocrates free and premium applications are continuously updated; so healthcare professionals always have the most current clinical information at their fingertips. The company’s offerings also enable communication between its users and healthcare organizations such as government agencies, pharmaceutical manufacturers and market research firms.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 11/01/04 | Series C | 6.4M | Genacast Ventures, New Atlantic Ventures., Savitr Capital, Daylight Partners, The NYC Seed Fund, Noi That Bep Xinh | Unknown |
People
Joe Kleine (SVP Sales)
Patrick Jones (Board Member)
John Voris (Board Member)
Les Mann (VP Sales & Marketing)
Kirk Loevner (President/CEO)
Competitors
Diagnosia:
Diagnosia.com is the leading European source for medical drug information . In collaboration with national and… See Company Profile »
Medfusion:
Medfusion, a Leading Provider of Patient-to-Provider Communication Solutions Our Mission is to enable healthcare providers to… See Company Profile »
News
Share Practice releases mobile app to help good doctors become great doctors
April 30, 2013 7:22 pm
What is the difference between a good doctor and a great doctor? According to Dr. Andrew Brandeis, it is experience,… Continue reading ⟩
Next round of HealthBeat speakers includes Stanford, Box, Doximity, and Kaiser Permanente
April 10, 2013 7:21 pm
Over the past decade, the vast majority of conferences dedicated to health information technology have been about the theoretical and… Continue reading ⟩
Funding Daily: If you haven’t got your health…
January 9, 2013 1:25 am
Health dominated the deals channel today. Venture capital reports, funding rounds, and acquisitions kept the blood flowing though the industry’s… Continue reading ⟩